Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Birch Pollen-induced Allergic Rhinoconjunctivitis

Allergon AB

Allergen

Allergon AB patent portfolio — 24 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
SE HQ
23 Employees
PMDA registrant Type
Company details
Status
Public
HQ
SE
Employees
23
Programs
1
Drugs
6
Patents
24
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Allergon AB patents

24 pharmaceutical patents indexed for Allergon AB. 0 expire within 24 months.

Allergon AB has 24 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

24 patents

Patent portfolio

  1. CN 112638413

    Oral immunotherapy unit dose dispensing systems and methods

    Expires Thu Apr 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2015187736

    FORMULATIONS PLACEBO ET UTILISATIONS DE CELLES-CI

    Expires Wed Dec 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 2014356438

    PERIPHERALLY ADMINISTERED VISCOUS FORMULATIONS

    Expires Wed Nov 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 2014271836

    MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION

    Expires Wed Sep 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 2014271721

    PEANUT FORMULATIONS AND USES THEREOF

    Expires Wed Sep 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 2013209398

    CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS AND METHODS OF USE

    Expires Wed Aug 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. CA 2849366

    COMPOSITIONS ET PROCEDES POUR TRAITER LA PRESBYTIE, L'HYPERMETROPIE LEGERE ET L'ASTIGMATISME IRREGULIER

    Expires Wed Mar 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 2012003230

    SUSTAINED RELEASE DRUG DELIVERY SYSTEMS COMPRISING A WATER SOLUBLE THERAPEUTIC AGENT AND A RELEASE MODIFIER

    Expires Wed Dec 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 2011062165

    BALANCED INDIVIDUAL DINING PLATE

    Expires Wed Mar 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 2010204127

    USE OF A BOTULINUM NEUROTOXIN TO ALLEVIATE VARIOUS DISORDERS

    Expires Wed Aug 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 2009239858

    THERAPEUTIC AMIDES

    Expires Wed Sep 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 2008241252

    METHODS AND COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION TO TREAT OCULAR CONDITIONS

    Expires Wed Sep 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. RU 2203884

    RETINOID COMPOUNDS (VARIANTS), COMPOSITION, METHOD FOR ASSAY OF RETINOID HORMONE ANTAGONISTS, METHOD OF TREATMENT AND INTERMEDIATE SUBSTANCES

    Expires Fri May 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 2003068250

    Compositions including vitamin-based surfactants and methods for using same

    Expires Wed Apr 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 2002161051

    (2-hydroxy)ethyl-thioureas useful as modulators of alpha2B adrenergic receptors

    Expires Wed Oct 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. RU 2191009

    METHODS OF THERAPY BY APPLYING THE COMPOUNDS EITHER OF SPECIFIC OR SELECTIVE ACTIVITY TO RETINAL ACID RECEPTOR RARalpha

    Expires Sat Oct 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 2002127247

    Modified clostridial neurotoxins with altered biological persistence

    Expires Wed Sep 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. CA 2433332

    AGENTS ET METHODES DE TRAITEMENT DE LA DOULEUR

    Expires Wed Jul 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6399774

    Compounds having activity as inhibitors of cytochrome P450RAI

    Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6313163

    2,4-pentadienoic acid derivatives having retinoid-like biological activity

    Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. CN 1311670

    Cholinergic agents in the treatment of presbyopia

    Expires Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. CN 1291100

    Cyclopentane Heptan (ene) oic acid, 2-hetero arylakenyl derivatives and therapeutic agents

    Expires Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. RU 2163906

    ARYL- OR HETEROARYLAMIDES OF TETRAHYDRONAPHTHALENE-, CHROMAN-, THIOCHROMAN- AND 1,2,3,4-TETRAHYDROQUINOLINE CARBOXYLIC ACIDS SHOWING RETINOID-LIKE BIOLOGICAL ACTIVITY

    Expires Fri Mar 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. CN 1284066

    Substituted inidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors

    Expires Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Allergon AB have?

24 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Allergon AB patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.